SEATTLE, Wash. — A lab in Seattle is seeing some promising results in their quest to find a cure for the coronavirus.
HDT Bio is working with several Seattle partner agencies to create a synthetic virus that would be safe to administer.
The team artificially creates the coronavirus, first through computer simulations, and then in the lab as a potential vaccine.
HDT Bio material scientist Amit Khandhar told KOMO News that their cutting edge technology is really the future.
Early tests are promising and clinical trials could begin as early as next month.
Federal approval for the vaccine could be a year or more away.